Zymergen recently became aware of issues with its commercial product pipeline that will impact the Company’s delivery timeline and revenue projections. Accordingly, the Company no longer expects product revenue in 2021, and expects product revenue to be immaterial in 2022.
ZY went public only three months ago (#msg-163354411); I commented then on how vague the corporate mission statement was. Maybe that was a red flag.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”